COMBINED PHARMACEUTICAL COMPOSITION OF CDK4/6 INHIBITOR AND AROMATASE INHIBITOR

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20240374593A1
SERIAL NO

18690198

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to a combined pharmaceutical composition of a CDK4/6 inhibitor and an aromatase inhibitor, and the use thereof in the treatment of breast cancer. Compared with separate administration of any agent in the composition, the combined pharmaceutical composition of the present disclosure yields a better therapeutic effect on slowing tumor growth or even eliminating tumors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTDLIANYUNGANG JIANGSU 222062

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
FENG, Fan Lianyungang, Jiangsu Province, CN 21 18
WANG, Yueting Lianyungang, Jiangsu Province, CN 3 0
YU, Ding Lianyungang, Jiangsu Province, CN 32 31
ZHANG, Xiquan Lianyungang, Jiangsu Province, CN 77 63

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation